G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis
- PMID: 23317786
- PMCID: PMC3632385
- DOI: 10.1016/B978-0-12-386933-3.00006-6
G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis
Abstract
Obesity and its related metabolic diseases have reached a pandemic level worldwide. There are sex differences in the prevalence of obesity and its related metabolic diseases, with men being more vulnerable than women; however, the prevalence of these disorders increases dramatically in women after menopause, suggesting that sex steroid hormone estrogens play key protective roles against development of obesity and metabolic diseases. Estrogens are important regulators of several aspects of metabolism, including body weight and body fat, caloric intake and energy expenditure, and glucose and lipid metabolism in both males and females. Estrogens act in complex ways on their nuclear estrogen receptors (ERs) ERα and ERβ and transmembrane ERs such as G protein-coupled estrogen receptor. Genetic tools, such as different lines of knockout mouse models, and pharmacological agents, such as selective agonists and antagonists, are available to study function and signaling mechanisms of ERs. We provide an overview of the evidence for the physiological and cellular actions of ERs in estrogen-dependent processes in the context of energy homeostasis and body fat regulation and discuss its pathology that leads to obesity and related metabolic states.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis.Adv Exp Med Biol. 2017;1043:427-453. doi: 10.1007/978-3-319-70178-3_20. Adv Exp Med Biol. 2017. PMID: 29224106 Free PMC article. Review.
-
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes.Sci Transl Med. 2020 Jan 29;12(528):eaau5956. doi: 10.1126/scitranslmed.aau5956. Sci Transl Med. 2020. PMID: 31996464 Free PMC article.
-
The role of hypothalamic estrogen receptors in metabolic regulation.Front Neuroendocrinol. 2014 Oct;35(4):550-7. doi: 10.1016/j.yfrne.2014.05.002. Epub 2014 May 29. Front Neuroendocrinol. 2014. PMID: 24882636 Free PMC article. Review.
-
Estrogen receptor signaling and targets: Bones, breasts and brain (Review).Mol Med Rep. 2024 Aug;30(2):144. doi: 10.3892/mmr.2024.13268. Epub 2024 Jun 21. Mol Med Rep. 2024. PMID: 38904201 Review.
-
Metabolic impact of sex hormones on obesity.Brain Res. 2010 Sep 2;1350:77-85. doi: 10.1016/j.brainres.2010.04.056. Epub 2010 May 23. Brain Res. 2010. PMID: 20441773 Free PMC article. Review.
Cited by
-
Estradiol treatment increases M2-like visceral adipose tissue macrophages in obese ovariectomized mice regardless of its anorectic action.Anim Cells Syst (Seoul). 2022 Sep 29;26(5):243-253. doi: 10.1080/19768354.2022.2128871. eCollection 2022. Anim Cells Syst (Seoul). 2022. PMID: 36275444 Free PMC article.
-
Metabolic and Epigenetic Regulation by Estrogen in Adipocytes.Front Endocrinol (Lausanne). 2022 Feb 22;13:828780. doi: 10.3389/fendo.2022.828780. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35273571 Free PMC article. Review.
-
GPER-induced signaling is essential for the survival of breast cancer stem cells.Int J Cancer. 2020 Mar 15;146(6):1674-1685. doi: 10.1002/ijc.32588. Epub 2019 Aug 7. Int J Cancer. 2020. PMID: 31340060 Free PMC article.
-
Roles of G protein-coupled estrogen receptor GPER in metabolic regulation.J Steroid Biochem Mol Biol. 2018 Feb;176:31-37. doi: 10.1016/j.jsbmb.2017.02.012. Epub 2017 Feb 20. J Steroid Biochem Mol Biol. 2018. PMID: 28223150 Free PMC article. Review.
-
Comparative Genomic Characterization of Buffalo Fibronectin Type III Domain Proteins: Exploring the Novel Role of FNDC5/Irisin as a Ligand of Gonadal Receptors.Biology (Basel). 2021 Nov 19;10(11):1207. doi: 10.3390/biology10111207. Biology (Basel). 2021. PMID: 34827201 Free PMC article.
References
-
- James WPT. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263(4):336–352. - PubMed
-
- Cummings DE, Schwartz MW. Genetics and Pathophysiology of Human Obesity. Annu Rev Med. 2003;54(1):453–471. - PubMed
-
- Alberti K, Zimmet P, Shaw J. IDF epidemiology task force consensus group: the metabolic syndrome—a worldwide definition. Lancet. 2005;366:1059–1062. - PubMed
-
- McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51(1):7–18. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical